...
首页> 外文期刊>Journal of materials science >Development preclinical evaluation and validation of a novel quick vascular closure device for transluminal, cardiac and radiological arterial catheterization
【24h】

Development preclinical evaluation and validation of a novel quick vascular closure device for transluminal, cardiac and radiological arterial catheterization

机译:用于腔内,心脏和放射动脉导管插入术的新型快速血管闭合装置的开发前临床评估和验证

获取原文
获取原文并翻译 | 示例

摘要

Following percutaneous coronary intervention, vascular closure devices (VCDs) are increasingly used to reduce time to ambulation, enhance patient comfort, and reduce potential complications compared with traditional manual compression. Newer techniques include complicated, more or less automated suture devices, local application of pads or the use of metal clips and staples. These techniques often have the disadvantage of being time consuming, expensive or not efficient enough. The VCD failure rate in association with vascular complications of 2.0-9.5%, depending on the type of VCD, is still not acceptable. Therefore, the aim of this study is to develop a self-expanding quick vascular closure device (QVCD) made from a bioabsorbable elastic polymer that can be easily applied through the placed introducer sheath. Bioabsorbable block-co-polymers were synthesized and the chemical and mechanical degradation were determined by in vitro tests. The best fitting polymer was selected for further investigation and for microinjection moulding. After comprehensive haemocompatibility analyses in vitro, QVCDs were implanted in arterial vessels following arteriotomy for different time points in sheep to investigate the healing process. The in vivo tests proved that the new QVCD can be safely placed in the arteriotomy hole through the existing sheath instantly sealing the vessel. The degradation time of 14 days found in vitro was sufficient for vessel healing. After 4 weeks, the remaining QVCD material was covered by neointima. Overall, our experiments showed the safety and feasibility of applying this novel QVCD through an existing arterial sheath and hence encourage future work with larger calibers.
机译:与传统的手动加压相比,在经皮冠状动脉介入治疗之后,越来越多地使用血管闭合装置(VCDs)来减少移动时间,提高患者舒适度并减少潜在的并发症。较新的技术包括复杂的,或多或少的自动缝合设备,垫的局部应用或金属夹和订书钉的使用。这些技术通常具有耗时,昂贵或不够有效的缺点。视VCD类型而定,VCD失败率与血管并发症相关的率为2.0-9.5%。因此,本研究的目的是开发一种由生物可吸收的弹性聚合物制成的自膨胀快速血管闭合装置(QVCD),该装置可以很容易地通过放置的导引器鞘套应用。合成了可生物吸收的嵌段共聚物,并通过体外测试确定了化学降解和机械降解。选择最合适的聚合物用于进一步研究和显微注射成型。在体外进行全面的血液相容性分析后,将QVCDs在绵羊切开后不同时间点植入动脉血管中,以研究其愈合过程。体内试验证明,新的QVCD可以通过现有的护套安全地放置在动脉切开孔中,从而立即密封血管。体外发现的14天降解时间足以使血管愈合。 4周后,剩余的QVCD资料被新内膜覆盖。总体而言,我们的实验表明,通过现有的动脉鞘套应用这种新型QVCD的安全性和可行性,因此鼓励将来使用大口径的工作。

著录项

  • 来源
    《Journal of materials science 》 |2018年第6期| 33.1-33.11| 共11页
  • 作者单位

    German Inst Text & Fiber Res DITF, Denkendorf, Germany;

    German Inst Text & Fiber Res DITF, Denkendorf, Germany;

    German Inst Text & Fiber Res DITF, Denkendorf, Germany;

    German Inst Text & Fiber Res DITF, Denkendorf, Germany;

    ITV Denkendorf Prod Serv GmbH, Denkendorf, Germany;

    ITV Denkendorf Prod Serv GmbH, Denkendorf, Germany;

    Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Tubingen, Germany;

    Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Tubingen, Germany;

    Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Tubingen, Germany;

    Univ Hosp Tuebingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany;

    Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Tubingen, Germany;

    Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Tubingen, Germany;

    Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Clin Res Lab, Tubingen, Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号